Cancer News and Research

Latest Cancer News and Research

Analysis: More progress needed before widespread adoption of healthcare value assessments

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of an analysis showing that while value assessment frameworks are moving closer to meeting the challenge of accurately measuring value and reliably informing healthcare decisions, more progress is needed before widespread adoption and use.

23 Sep 2019

MD Anderson and Houston Dynamo join hands to kick childhood cancer

The University of Texas MD Anderson Cancer Center goes gold for Kick Childhood Cancer Awareness Night at BBVA Stadium, Saturday, Sept. 21 at 7:30 p.m. as the Houston Dynamo take on Orlando City SC, a professional soccer club in Orlando, Florida.

23 Sep 2019

Discrete choice experiments can predict real-world healthcare choices, research shows

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of research demonstrating that discrete choice experiments are able to predict real-world healthcare choices.

23 Sep 2019

Data on health-related quality of life often not collected for investigational cancer drugs

A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

23 Sep 2019

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

23 Sep 2019

New study identifies potential enzyme target for diabetic retinopathy

A new study shows that diabetic retinopathy (DR), or retinal disease caused by the high blood glucose levels in diabetes mellitus, is due to the death of retinal cells because of the high levels of a pro-enzyme called lysyl oxidase propeptide (LOX-PP). This could help researchers develop specific treatments by targeting this molecule.

22 Sep 2019

Identification and management of depression in people with epilepsy to save lives

Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.

21 Sep 2019

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Five innovative cancer-fighting projects at The University of Texas Health Science Center at Houston received just over $11 million during the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas

21 Sep 2019

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.

21 Sep 2019

Open Medicare data provides critical insights on hidden costs of health care

An interdisciplinary team of Indiana University scientists studying Medicare data have found an association between health care industry payments to medical providers for non-research expenses and what these providers charge for medical services -- shedding new light on potential hidden costs to the public.

20 Sep 2019

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

Stephenson Cancer Center Testing Drug for Prostate Cancer Patients on Active Surveillance OKLAHOMA CITY - Men who are diagnosed with low-risk prostate cancer usually opt for active surveillance - a monitoring of their cancer over time without undergoing treatments that would cause side effects.

20 Sep 2019

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

In early July, the German Institute for Quality and Efficiency in Health Care conducted two early benefit assessments to investigate whether certain drug combinations with pembrolizumab have advantages in comparison with the respective appropriate comparator therapy for patients with metastatic squamous or non-squamous non-small cell lung cancer.

20 Sep 2019

Penn researchers develop novel vaccine to protect against genital herpes

Researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a vaccine to protect against genital herpes.

20 Sep 2019

Scientists identify new family of drugs which could combat prostate cancer

A new family of drugs which inhibit the activity of a protein associated with prostate and other cancers has been reported by scientists from the University of Bath.

20 Sep 2019

Study provides new insight into how cells maintain their identity

In the body's cells, some proteins are of vital importance as to which genes are active or turned off. Now, researchers from the University of Copenhagen and the Memorial Sloan Kettering Cancer Center have discovered which proteins are necessary in order to maintain the proper genetic regulation.

20 Sep 2019

Cancer News and Research

Latest Cancer News and Research

Analysis: More progress needed before widespread adoption of healthcare value assessments

MD Anderson and Houston Dynamo join hands to kick childhood cancer

Discrete choice experiments can predict real-world healthcare choices, research shows

Data on health-related quality of life often not collected for investigational cancer drugs

Conference reviews effects of tobacco products, underscores the importance of oral health

New study identifies potential enzyme target for diabetic retinopathy

Identification and management of depression in people with epilepsy to save lives

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Open Medicare data provides critical insights on hidden costs of health care

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

Penn researchers develop novel vaccine to protect against genital herpes

Scientists identify new family of drugs which could combat prostate cancer

Study provides new insight into how cells maintain their identity

Developing cost-effective and milder synthetic routes to create oxygen heterocycles

Researchers discover potential approach to treating diabetic retinopathy

Sponge-like action of circular RNA aids tissue repair after heart attack

Researchers develop world's first blood incubator using laser technology

New prediction models for improved treatment of lymph nodes in breast cancer patients

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in